FindTrial
Sign In

Effect of different doses of esketamine in prevention of traction reaction during cesarean section of scarred uterus

Effect of different doses of esketamine in prevention of traction reaction during cesarean section of scarred uterus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086940
Enrollment
Unknown
Registered
2024-07-15
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

Group E1:0.1mg/kg esketamine
Group E2:0.2mg/kg esketamine
Group E2:0.3mg/kg esketamine
Group C:Equal volume of normal saline

Sponsors

Guanyun people's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: ASA I/II; 20-45 years old; BMI 18.8-30.0kg/m^2; 37-42 weeks gestation.

Exclusion criteria

Exclusion criteria: ? Contraindications to spinal anesthesia; ? Complicated with gestational hypertension; ? Liver or kidney dysfunction; ? Complicated with severe cardiopulmonary disease; ? Placenta previa; ? Intrauterine fetal distress; ? Allergic or intolerant to any study drug.

Design outcomes

Secondary

MeasureTime frame
Ramsay score;Satisfaction score after surgery;Occurrence of adverse reactionsrelated to esketamine;—

Primary

MeasureTime frame
Incidence of intraoperative traction reaction;—

Countries

China

Contacts

Public ContactQian Long

Guanyun people's Hospital

xqianlong@126.com+86 152 5124 5520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026